PRODUCT

KLOW Protocol

No short description available.

Woundhealing

effective

Multi-Modal Healing
Addresses tissue repair through multiple complementary pathways
Enhanced Tolerability
KPV may reduce injection site reactions compared to GLOW
Convenience Factor
Single injection versus four separate peptides

Recovery

effective

Post-Surgical Recovery
User reports of enhanced healing - no clinical validation
Sports Injury Support
Athletes report benefits - banned by WADA
Skin Rejuvenation
Aesthetic applications reported but unverified

Antiinflammatory

effective

GLOW Protocol

Use Caution

KLOW already contains all GLOW components plus KPV - combining would result in double dosing of base peptides

Ipamorelin

Unknown

No studies on combination - theoretical compatibility based on different mechanisms

NAD+

Unknown

No data on combining KLOW with NAD+ - both affect cellular processes through different pathways

Anticoagulants

Use Caution

Components may affect wound healing and clotting - medical supervision required

Growth Hormone

Avoid Combination

Multiple components affect GH pathways - risk of excessive stimulation

Immunosuppressants

Use Caution

Components may interfere with immunosuppressive therapy - consult physician

Common Research Protocol:3.2mg total (2mg GHK-Cu, 400mcg each TB500/KPV/BPC-157)Once daily
Starter/Titration Protocol:2mg total (1.25mg GHK-Cu, 250mcg each TB500/KPV/BPC-157)Once daily
Cycling Protocol:As above4-6 weeks on, 2-4 weeks off

Route:injectable

Route:injectable

Resources